Click a link below to view the mailing archive as if it had been sent to you.
| 2024-09-30 12:15 | | Roche targets more than $3 billion in annual obesity sales and more... |
| 2024-09-27 00:15 | | Experts support FDA's plan for restrictions on PD-1 drugs in stomach, esophageal cancers and more... |
| 2024-09-26 12:15 | | Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end and more... |
| 2024-09-26 00:15 | | Pfizer issues global market withdrawal of sickle cell disease therapy Oxbryta and more... |
| 2024-09-25 12:15 | | Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic and more... |
| 2024-09-25 00:15 | | With Novo CEO on the hot seat at Senate hearing, PBMs and insurance concerns get the spotlight and more... |
| 2024-09-24 12:15 | | Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar and more... |
| 2024-09-24 00:15 | | Sanofi CEO believes company poised for growth from new drugs and more... |
| 2024-09-23 12:15 | | Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M and more... |
| 2024-09-23 00:15 | | With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine and more... |
| 2024-09-20 12:15 | | Novo obesity prospect linked to ‘mild to moderate neuropsychiatric side effects’ in phase 2 and more... |
| 2024-09-20 00:15 | | New migraine drugs less effective than previous generation of triptan meds: BMJ study and more... |
| 2024-09-19 12:15 | | Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says and more... |
| 2024-09-19 00:15 | | FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma and more... |
| 2024-09-18 12:15 | | FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor and more... |
| 2024-09-18 00:15 | | 23andMe independent directors quit board over unsatisfactory buyout plan from CEO and more... |
| 2024-09-17 12:15 | | Obesity pill race heats up as Novo, Roche and Terns share data and more... |
| 2024-09-17 00:15 | | B+L Rumored to be Looking at Potential Sale to Fully Separate from Parent Company and more... |
| 2024-09-16 12:15 | | Ipsen shelves Cabometyx combo in prostate cancer after Phase III miss and more... |
| 2024-09-16 00:15 | | ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in liver cancer subtype and more... |
| 2024-09-13 12:15 | | Neurocrine's bid to save schizophrenia prospect fails and more... |
| 2024-09-13 00:15 | | Bavarian Nordic eyes external partnerships in bid to produce tens of millions of mpox vaccine doses and more... |
| 2024-09-12 12:15 | | Moderna targets $1.1B in R&D spending cuts, drops 5 programs amid profitability pressures and more... |
| 2024-09-12 00:15 | | Lilly delivers one-two punch with 2nd tranche of positive data on weekly insulin candidate and more... |
| 2024-09-11 12:15 | | Roche ramps up R&D with $1.4B Swiss facility and more... |
| 2024-09-11 00:15 | | Physicians rank pharma corporate reputation as top factor in prescribing decisions and more... |
| 2024-09-10 12:15 | | BIOSECURE Act sails through House passage, lines up Senate vote and more... |
| 2024-09-10 00:15 | | As Sandoz contract winds down, GSK will close antibiotics plant in UK and more... |
| 2024-09-09 12:15 | | Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data and more... |
| 2024-09-09 00:15 | | J&J bolsters Rybrevant-Lazcluze's case against AZ's Tagrisso with survival analysis and more... |
| 2024-09-06 12:15 | | FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance and more... |
| 2024-09-06 00:15 | | Lykos CEO to depart after FDA rejection, layoffs and more... |
| 2024-09-05 12:15 | | Eli Lilly says experimental insulin could mean 313 fewer injections per year and more... |
| 2024-09-05 00:15 | | BioMarin, having retrenched, outlines plans for growth and more... |
| 2024-09-04 12:15 | | ArsenalBio raises $325M in one of the year’s largest biotech funding rounds and more... |
| 2024-09-04 00:15 | | New research could ease concerns over suicide risk of obesity drugs and more... |
| 2024-09-03 12:15 | | Bayer’s kidney disease drug Kerendia reduces cardiovascular risk by 16% and more... |
| 2024-09-03 00:15 | | Novo Nordisk's Ozempic shortage expected to continue into Q4 and more... |
